November 30, 2007 — Elan Pharmaceuticals Inc. has licensed Pathway Studio software from Ariadne Inc. to help interpret microarray data.
Ariadne’s Pathway Studio includes the ResNet database of functional relationships that can be used for assembly of biological pathways, exploring signaling networks, and to interpret microarray experimental data. MedScan’s natural language processing technology enables customers to extend ResNet though extraction of pathway-related information from biomedical literature.
“Ariadne’s Pathway Studio, MedScan and ResNet complement the tools already in use at Elan for pathway investigation and gene expression analysis,” Jim Miller, principal scientist at Elan Pharmaceuticals, said in a news release. “The MedScan module, in particular, gives a scientist the capability to quickly create pathways from the newest literature sources in a matter of minutes.”